Tunde Golenar, PhD

Tunde Golenar, PhD has a diverse work experience in the field of cancer research. Tunde is currently employed at Congruence Therapeutics as a Senior Scientist since December 2021. Prior to this, they worked as a Research Intern at Congruence Therapeutics from September 2021 to January 2022.

Earlier in their career, Tunde served as a Graduate Student at the Rosalind and Morris Goodman Cancer Centre from January 2015 to January 2022. During this time, they gained valuable knowledge and skills in cancer research.

Tunde began their research career at Thomas Jefferson University in 2009, where they worked as a Research Technician until January 2015. This experience provided him with a foundation in scientific research techniques and methodologies.

Overall, Tunde Golenar, PhD has a strong background in cancer research and has held various positions that have contributed to their expertise in the field.

Tunde Golenar, PhD, has an impressive education history in the field of biochemistry. Tunde completed their Doctor of Philosophy degree from McGill University, specializing in Biochemistry, from 2015 to 2021. Prior to that, they attained their Master's degree in Molecular Biology from the University of Szeged, which they pursued from 2002 to 2007.

Furthermore, Tunde Golenar has obtained additional certifications to enhance their expertise. Tunde completed the Good Clinical Practice (GCP)-Canada certification from the CITI Program, A Division of BRANY, in January 2021. Tunde also acquired the Health Canada Division 5-Drugs For Clinical Trials Involving Human Subjects certification from the same institution and in the same month and year.